Episode 92 | Nick Accordino and Will Braeutigam: Deloitte | Taking your Medtech Company Public: SPACs vs. IPOs
1 tim 9 min•9 maj 2022
- In this episode, Nick Accordino and Will Braeutigam from Deloitte and Duane Mancini discuss discuss SPACs, what are SPACs, why would a company want to go public, the differences in going public through an IPO vs. SPAC, strategic acquisition vs. going public, the myths of going public via a SPAC, preparing your company to go public, and so much more.
- Nick Accordino LinkedIn
- Will Braeutigam LinkedIn
- Deloitte Website
- Project Medtech Website
- Duane Mancini LinkedIn
- Project Medtech LinkedIn
Fler avsnitt av Project Medtech
Visa alla avsnitt av Project MedtechProject Medtech med Project Medtech finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.